National Children’s Study Federal Advisory Committee Member
Dr. Henry is an advisor and consultant to public and private organizations, focusing on issues in toxicology, public and environmental health, biomonitoring, risk assessment and risk management, research management and strategies, and domestic and international science policy. She retired as Vice President, Industry Performance Programs (IPP) at the American Chemistry Council (ACC) in November 2007. At ACC, she was responsible for executive management and strategic direction for ACC’s four public service performance programs: Responsible Care®, Long-Range Research Initiative (LRI), CHEMTREC®, and Economics and Statistics. These Industry Performance Programs strengthen the foundation of ACC’s public policy and product stewardship efforts.
Previously, Dr. Henry served as Vice President, Science and Research, at ACC, as Director of the Health and Environmental Sciences Department of the American Petroleum Institute, as Associate Deputy Assistant Secretary for Science and Risk Policy at the U.S. Department of Energy, as Director of the Office of Environmental Health Hazard Assessment (OEHHA) at the California Environmental Protection Agency, and as Executive Director of the International Life Sciences Institute’s Risk Science Institute.
Dr. Henry received her undergraduate degree in chemistry from the University of Minnesota and doctorate in microbiology from the University of Pittsburgh. In addition, Dr. Henry held postdoctoral fellowships in biochemistry at the Max Planck Institute in Germany, in biology at Princeton University, and biochemistry/cancer research at the Sloan Kettering Institute.
A diplomate of the American Board of Toxicology, Dr. Henry is a member of the American College of Toxicology, of which she has been president; the Society of Toxicology; the American Association for Cancer Research; the American Association for the Advancement of Science; and the American Chemical Society, where she was elected to and currently serves on the Board of Managers of the Chemical Society of Washington. She was a member of the National Research Council’s Committee on Human Biomonitoring of Environmental Chemicals, and the Committee to Evaluate Research Efficiency at the Environmental Protection Agency. She currently serves on the Roundtable on Environmental Health Sciences, Research, and Medicine of the Institute of Medicine; Environmental Health Perspectives Editorial Review Board; and as Co-Chair of the Science Advisory Board for the Harvard School of Public Health-Cyprus International Initiative for the Environment and Public Health.